#adalimumab

[medicomunicare]

I farmaci modificanti della malattia (DMARDs): un cardine essenziale per trattare le malattie autoimmuni

I farmaci modificanti il decorso della malattia (Disease-Modifying Antirheumatic Drugs; DMARDs) sono una classe di farmaci utilizzati principalmente nelle malattie autoimmuni e reumatologiche per modificare il decorso della malattia e rallentare la progressione del danno tissutale, migliorando la qualità della vita e riducendo i sintomi. I DMARDs comprendono farmaci convenzionali sintetici,…

[kexingbiopharm]

Adalimumab Solution for Injection

Adalimumab(Ahrasin) is a fully human anti-tumor necrosis factor-α(TNF-α) monoclonal antibody, a biosimilar drug of HUMIRA. Excessive inflammation in a variety of immune-mediated diseases in humans is associated with TNF-α.

[drpedi07]

Adalimumab Drug

Medical information for Adalimumab on Pediatric Oncall including Indication, Dosing, Adverse Effect, Hepatic Dose.

[biglisbonnews]

The price of Humira's biosimilars can uncloak the secret villain of US drug pricing Pharmaceutical giant AbbVie was able to delay competition to its blockbuster arthritis drug, Humira, into the US market for many years. But Americans can finally choose from one of several arthritis biosimilars, as generics for complex molecule drugs are known.Read more... https://qz.com/the-price-of-humiras-biosimilars-can-uncloak-the-secret-1850225976

[jcrmhscasereports]

Bisphosphonates combined with TNF inhibitor (Adalimumab) in the treatment of tibial osteomyelitis in children by Chen Li in Journal of Clinical Case Reports Medical Images and Health Sciences 

ABSTRACT

A 15-year-old girl had intermittent pain in her left leg since October 2020. The imaging examination suggested that tibial tumors were not excluded. Bone biopsy showed chronic osteomyelitis. Another lesion resection was performed. The postoperative pain was not relieved. The patient came to our hospital for treatment. The X-ray, three-dimensional reconstruction CT and MRI of the left lower leg all showed obvious bone damage and bone thickening. (Figure.1A、B and C). Therefore, we consider aseptic osteomyelitis, which belongs to the category of SAPHO in children, and that can have no skin manifestations. In this case, the diagnosis is mainly based on the typical radiological manifestations of the patient [1]. Bisphosphonates were given for 3 months. The pain of the patient's left leg was significantly less than before, and there was still swelling of the left lower limb and limited movement. After treatment with TNF inhibitor (adalimumab), the swelling of the left leg subsided significantly. The written consent of the patient has been obtained with regard to the use of information such as the patient's clinical disease for education or scientific research. This case is a rare manifestation of tibial involvement of SAPHO. Bisphosphonate sequential TNF inhibitor can be used to improve the condition of children.

Keywords: SAPHO, tibial osteomyelitis, children

Figure1: The X-ray，three-dimensional reconstruction CT and MRI of the left lower leg. (A) The frontal and lateral X-ray film of the left leg shows that the bone mineral density in the lower segment of the left tibia is uneven, and the bone cortex is rough and irregular. (B) Three dimensional reconstruction CT of the left leg showed that the bone cortex of the lower segment of the left tibia was not smooth, and bone destruction, bone thickening and sclerosis were seen locally. (C) MRI of the left leg showed that the local bone cortex of the lower segment of the left tibia was not smooth, local bone defects and destruction were visible, and patchy slightly long T1 and long T2 signals were visible.

Conflict of Interest: No conflict of interest was declared by the authors.

For more information: https://jmedcasereportsimages.org/about-us/

For more submission : https://jmedcasereportsimages.org/

[bidhuan]

Produk Biosimilar Adalimumab Untuk Penyakit Kulit Kronis Disetujui FDA

Produk Biosimilar Adalimumab Untuk Penyakit Kulit Kronis Disetujui FDA

Majalah Farmasetika – Adalimumab-aacf (Idacio) diindikasikan untuk kondisi kronis seperti artritis reumatoid, psoriasis plak, kolitis ulserativa, artritis psoriatis, hidradenitis suppurativa, dan artritis idiopatik remaja. FDA telah menyetujui biosimilar adalimumab-aacf (Idacio) dari Fresenius Kabi untuk pengobatan beberapa kondisi dermatologis kronis. Ini menandai biosimilar kedelapan dari…

[collecting--stardust]

i fucking swear they just put random words and go okay that will be the name for the drug we just invented

[omkarmeds]

Meropenem Injection Supplier Bangalore has Consistent Stock for Such Injection!

People choose Meropenem injection because it is a powerful antibiotic that is used to treat serious bacterial infections. The injection is also used when other antibiotics are not effective or even when the infection is severe. And it works by killing bacteria and stopping their growth which helps the body fight off the infection. The leading Meropenem injection supplier Bangalore is the top choice as they are known for providing high quality injections which are important for treating serious bacterial infections. This supplier has built a strong reputation for reliability, quality and for their excellent customer service and making them the go to option for many hospitals, clinics and even healthcare providers in Bangalore.

Doctors mainly prescribe this injection for infections in different parts of the body like the lungs, abdomen, urinary tract and also the skin. It is also used to treat infections in the brain such as meningitis. This injection is especially important for patients who are in the hospital with serious infections that need strong and fast acting treatment. With this Meropenem injection supplier Bangalore you can get the best quality Meropenem. They work with trusted manufacturers who follow strict quality control measures to ensure that each injection is safe and effective too. This means that when you choose this supplier you can trust that you are getting a product that meets the highest standards. The importance of quality cannot be overstated especially when it comes to medications like Meropenem which is used to treat severe and life threatening infections.

Another reason this supplier is highly choose is their reliability. When healthcare providers need Meropenem injections they also need them quickly. This Meropenem injection supplier Bangalore understands the urgency and ensures that they have a consistent stock of injections available. They offer prompt delivery services throughout Bangalore so clinics and hospitals can always believe on them to get the medications they need on time. This level of reliability is important in the healthcare industry and where suitable access to medications can make a major difference in patient outcomes.

People choose a commode chair for several practical and health related reasons. This chair is a moveable toilet that can be used in different locations such as beside the bed or in any room where it is needed. And it is especially useful for people who have difficulty reaching the bathroom due to mobility issues, illness or even recovery from surgery. One of the main reasons people choose a commode chair is for convenience. They are the top commode chair dealers in Bangalore and selling the top quality chair for you.

Commode chair dealers in Bangalore

Safety is another important reason why people go for a commode chair. For elderly individuals or those with limited mobility getting to the bathroom can be a dangerous task. The risk of slipping or falling increases when they have to walk a distance and especially if they are unsteady on their feet. Purchasing from the commode chair dealers in Bangalore can minimize this risk by providing a stable and easy to reach option. These chairs are designed to be comfortable and they are user friendly too. They mainly have padded seats and backrests which make them more comfortable than a regular toilet for people who need to sit for longer periods. Some models also have adjustable heights that allow users to customize the chair to their needs.

Author’s Bio:

Omkar Meds is the top Meropenem injection supplier Bangalore. As one of the leading commode chair suppliers in Bangalore, he strives hard to bring convenient to use commode chairs in cheap.

[trendingrepots]

Adalimumab Market - Forecast(2024 - 2030)

Adalimumab Market Overview

Adalimumab Market Size is forecast to reach $3245.8 Million by 2030, at a CAGR of 6.20% during forecast period 2024-2030. Adalimumab is a monoclonal antibody and disease-modifying antirheumatic medication that acts by inactivating tumor necrosis factor-alpha. It is marketed under the brand names Humira and Exemptia, among others. The original adalimumab drug is sold under the brand name Humira. New versions of adalimumab are known as adalimumab biosimilars. Biosimilars are similar versions of original biological medicines. Adalimumab is a drug used to treat rheumatoid arthritis and ankylosing spondylitis which affects the musculoskeletal system, Crohn’s disease, ulcerative colitis, psoriatic arthritis, hidradenitis suppurativa, and other diseases. It was first introduced in the United States by Abbvie and was approved by the FDA in 2002. It is used to alleviate inflammation by acting on the immune system. The growing prevalence of arthritis and skin disorders, adoption of a sedentary lifestyle, and growing obese population are some of the factors driving the Adalimumab Market growth during the forecast period 2024-2030.

 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞

Report Coverage

The report: “Adalimumab Market Forecast (2024-2030)", by Industry ARC covers an in-depth analysis of the following segments of the Adalimumab Market.

By Disease- Crohn’s disease, Psoriatic arthritis, Rheumatoid arthritis, Ulcerative colitis, and others. By Type- Adalimumab, Adalimumab Biosimilar. By End-Users- Hospitals, Specialty Clinics, and Others. By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (the Middle East, and Africa).

Key Takeaways

Geographically, North America held a dominant market share in the year 2021 on account of the increasing prevalence of psoriasis arthritis, highly informed people knowing the benefits of adalimumab, and high healthcare expenditure. Asia-Pacific is expected to offer lucrative growth opportunities to the manufacturers owing to increasing prevalence of Crohn's disease and ulcerative colitis., demand for better healthcare facilities as well a boost in the investments done by government and private companies in pharma industry. The proliferation of Rheumatoid arthritis is predicted to augment the market growth during the forecast period of 2022-2027.

The growing prevalence of arthritis and skin disorders is estimated to drive the market growth of the Adalimumab Market. High cost as well as lack side effects of adalimumab poses threat to the market growth.

A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Adalimumab Market Report.

[krishgen]

Adalimumab ELISA Kit: Accurate Quantification by Krishgen

Krishgen presents its cutting-edge Adalimumab ELISA Kit, a powerful tool for precise and reliable quantification of Adalimumab, a widely used monoclonal antibody in the field of autoimmune disease research and therapeutic monitoring. Krishgen's Adalimumab ELISA Kit offers precise Adalimumab quantification for research and diagnostics. Trust in accuracy and efficiency with Krishgen.

[truthwithlight]

😭 the insurance stuff just keeps getting worse? it turns out they're breaking federal law? they're using a copay accumulator (see: making the medication manufacturer copay assistance card run out so they can change us), which you can't do on biologic medications

biosimilars don't count as generic medications, and accumulators can only be used on name brand medications that have generic versions. so them doing this with adalimumab / humira biosimilars is against federal law

i cannot fucking believe this i'm so tired i just want my joint meds

[somuchtostudysolittletime]

19/3/23 // 15.36

Two days to write 2000 words seems to be my thing. Here’s a trial about vedolizumab, my study setup, a mocha that I made, and some thoughts on adalimumab. Nearly done I think! (Hope!)

[mirabelmadrigal2310]

Treatment for Psoriatic Arthritis

Psoriatic arthritis is a chronic inflammatory condition that affects individuals with psoriasis, a skin disorder characterized by red, scaly patches. Treatment for psoriatic arthritis aims to alleviate symptoms, reduce inflammation, and prevent joint damage. Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen may be prescribed to manage pain and inflammation. Disease-modifying antirheumatic drugs (DMARDs) like methotrexate or sulfasalazine are often used to slow down the progression of joint damage. In cases of more severe disease, biologic medications, such as tumor necrosis factor (TNF) inhibitors like adalimumab or etanercept, may be recommended to target specific components of the immune system responsible for inflammation. Additionally, lifestyle modifications, including regular exercise, a balanced diet, and stress management, can contribute to overall well-being and help manage symptoms of psoriatic arthritis.

[heldhram]

Whoever came up with drug names such as idarucizumab, adalimumab, pegfilgrastim and dapagliflozin, I need to have a word with you

[exeggcute]

Humira is in the NYTs and not for good reasons!

for a second I was scared this was gonna be one of those "twenty-year cohort study suggests that long-term humira use causes patients to grow a tiny third arm on their back that gives people the finger all day"-type headlines so I am actually kinda relieved this is "just" about abbvie's patent law loophole fuckery lol. also thank god generic adalimumab is hitting the US market soon. this is gonna be life-changing so for many people...